Hikal Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Partnering with Pharmaceutical, Life Sciences, Biotech & Specialty Chemicals Companies to deliver APIs, Intermediate & R&D Services.
One of their notable products is PREGABALIN USP, with a corresponding US DMF Number 28663.
Remarkably, this DMF maintains an Active status since its submission on September 19, 2014, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 18, 2018, and payment made on December 06, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II